Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo
about
Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical StudiesA central role for inducible heat-shock protein 70 in autoimmune vitiligoVitiligo: interplay between oxidative stress and immune systemHighlights in pathogenesis of vitiligoMeta-Analysis of the Association between Vitiligo and Human Leukocyte Antigen-AEvolution, immunity and the emergence of brain superautoantigensCoherent somatic mutation in autoimmune disease.Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.The role of IL-17 in vitiligo: A reviewHeat Shock Protein-70 Expression in Vitiligo and its Relation to the Disease Activity.Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo.The pathogenesis of vitiligo.Stability in Vitiligo: Is there a Perfect Way to Predict it?Nonsegmental vitiligo and autoimmune mechanism.Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries.Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.Identification of the Risk HLA-A Alleles and Autoantigen in Han Chinese Vitiligo Patients and the Association of CD8+T Cell Reactivity with Disease Characteristics
P2860
Q26784310-415D83F4-2300-4FB4-9A4E-B3D5CD6C7CB2Q26823593-05ACA958-9BD4-4DD5-847C-BFE0E4DBDCCDQ26824504-287B32D1-1C30-462C-8F54-1111311E3471Q26851509-B022D533-E5DF-4855-94CC-B33B1192D7F0Q28076708-F1BD08EF-6EA0-496F-905B-4B639A86F1B6Q33642424-5A885BC3-56AA-4978-A343-37EEC5F993EFQ33837769-576C3C94-A426-419D-BAAC-30443EAE43CDQ34516054-6B72A8AB-6263-4899-95C2-C99B9051A773Q36625953-6AEA697C-0C2E-467B-A493-E4BA5B3AD7BAQ37138056-48A08F61-51AD-401B-A13C-CCF4CB552BA1Q37399612-68137D27-D4E4-417B-AB14-C906D3AF6C56Q37611016-B397F00F-F79A-4DFF-ADC4-3AD0B12AE660Q38025487-75E93B0A-CBBC-4BC3-BA3B-43CECA1E8582Q38106804-31C1F045-14BC-4721-A0B6-A10C7E3A7D4EQ38136173-2D5A6904-99F5-4B5B-8D39-C7AD03112884Q41954249-86AA3D3A-BA71-4F0E-8D41-E99E5A07EAC2Q42154142-772046DF-C60B-4723-98EF-C7A8B4C0378CQ46953146-B8254F30-CF95-4E57-9641-EA47A15B1BA5Q50876213-5ED18784-BC53-4C99-905B-385FA36F4C7EQ55058396-CB44E77D-D181-44B4-BAAB-171D08F4CD9EQ58735924-588636FF-A527-468C-94E2-3A9FE2EEA0B9
P2860
Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo
description
im Jahr 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Autoantibodies against tyrosin ...... gmental (generalised) vitiligo
@en
Autoantibodies against tyrosine hydroxylase in patients with non-segmental
@nl
type
label
Autoantibodies against tyrosin ...... gmental (generalised) vitiligo
@en
Autoantibodies against tyrosine hydroxylase in patients with non-segmental
@nl
prefLabel
Autoantibodies against tyrosin ...... gmental (generalised) vitiligo
@en
Autoantibodies against tyrosine hydroxylase in patients with non-segmental
@nl
P2093
P2860
P1476
Autoantibodies against tyrosin ...... gmental (generalised) vitiligo
@en
P2093
Anthony P Weetman
David J Gawkrodger
Philip F Watson
Samia Akhtar
Sherif Emhemad
P2860
P356
10.1111/J.1600-0625.2010.01181.X
P407
P577
2011-01-01T00:00:00Z